WeVote
Log In

Bill

MB

Bill

HR 8022

DETECT Nitazenes Act of 2026

119th Congress Introduced by Michael Baumgartner and 1 co-sponsor

Bill schedules synthetic opioid nitazenes as controlled substances, enabling federal enforcement against trafficking and possession of this increasingly detected street drug.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 8022

Legislative bill overview

The DETECT Nitazenes Act of 2026 seeks to add nitazenes—a class of synthetic opioids—to the Drug Enforcement Administration's list of controlled substances. Nitazenes are increasingly appearing in illicit drug supplies alongside or instead of fentanyl, and this bill aims to establish federal regulatory authority over their manufacture, distribution, and possession.

Why is this important

Nitazenes have emerged as a significant public health threat, being detected in overdose deaths across multiple states and often sold deceptively as other drugs. Federal scheduling would enable law enforcement to prosecute nitazene-related crimes, support treatment and research initiatives, and potentially disrupt supply chains before these substances become more widespread in communities.

Potential points of contention

  • Scheduling approach timing: Critics may argue that emergency scheduling procedures would be faster than standard legislation, while proponents contend congressional action creates more durable legal frameworks
  • Analogue compounds: Nitazene variants and chemical analogues may continue emerging, raising questions about whether this bill adequately addresses derivative compounds or requires repeated legislative updates
  • Resource allocation: Law enforcement and public health resources directed toward nitazene enforcement represent trade-offs with other drug control priorities, raising debate about relative threat levels compared to fentanyl and methamphetamine

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.